Blogs and Podcasts
Expertise in Pharmaceutical Solutions and Health Surveillance and Diagnostics
Blogs and Podcasts
Ebola Response Deployment
In March 2014, the World Health Organization (WHO) reported cases of Ebola Virus Disease (EVD) in the forested rural region of southeastern Guinea. In response, the team at MRIGlobal took a multidisciplinary approach to design and build laboratory diagnostic capabilities for use in remote areas without strong public health systems – and ready to deploy in six weeks.
Multi-Target DiagnosticS
It is flu season and there can be significant challenges diagnosing it and other respiratory illnesses like RSV and SARS-CoV-2 due to overlapping symptoms, which is why a multi-target diagnostic can be particularly useful.
Preventive Measures to Mitigate H5N1
A new variant of H5N1 has been impacting wild bird and mammal populations, domesticated farm animals, and has made the jump to the human population. Preventive measures like agricultural biosurveillance and vaccines can help limit its impact.
Field Forward Detection and Diagnostics
Infectious diseases can emerge from anywhere in the world, and when they do, it’s critical that officials are prepared with detection and diagnostic methods for use in environments that have space, time, and resource constraints. Jennifer Stone shares with us how field forward detection and diagnostic devices are developed and their role in providing care to remote communities around the world.
Bioinformatics in Viral Genome Understanding
Bioinformatics is pivotal in the development of molecular and antigen test assays for viral respiratory diseases. Its use enables a wider and deeper understanding of the viral genome and its characteristics that might be relevant to designing effective diagnostic tools.
Infectious Disease Assay Development
Respiratory illnesses are generally characterized by a fever, a cough, and a sore throat. These kinds of infections are common during fall and winter and can occur in either the upper or lower respiratory tract. As the winter season gives way to spring, you may be reflecting on your own recent bouts of illness. Within, we recommend six stages to developing a novel infectious disease assay in advance of the next respiratory virus season.
Navigating Regulatory Challenges
Based on our observations, approximately 75 percent of the market has experienced a lack of clarity about regulatory requirements or FDA expectations for study designs. Our expertise in working with the FDA can help ensure clarity in study design and navigate associated regulatory challenges.
Pharmaceutical Repository Supports Clinical Trials
MRIGlobal’s repository services are a support solution for chemicals ranging from industrial compounds posing human health concerns to natural products, drug substances, drug products, and clinical trial materials. Having recently expanded this space at our North Kansas City facility, we offer full-service repository management support for pharmaceutical companies needing to store their samples. With this same repository services facility also now being licensed as a Foreign-Trade Zone (FTZ), materials can easily be brought into this country and stored while awaiting FDA approval.